This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
ACS
The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has granted its year-end 2017 Outstanding Achievement Award to a select group of 16 accredited cancer programs throughout the United States. Award criteria were based on qualitative and quantitative surveys of cancer programs conducted during the second half of 2017.
READ MORE
Targeted Oncology
Two selective inhibitors of the rearranged during transfection (RET) kinase have shown early efficacy in phase I studies of patients with various solid tumors harboring RET alterations, offering a potential new treatment option for patients with RET-altered tumors with reduced toxicity.
READ MORE
|
Promoted by
|
|
|
|
 |
ScienceDaily
Using worm experiments, scientists were able to study the processes generating cancer-causing DNA mutations in detail. The findings help identify the causes of human cancer. Such insights could be an important first step in identifying possible directions for new cancer treatments.
READ MORE
OncLive
The market for biosimilar introduction is "extremely unstable," but the FDA is working to ease the launch of more affordable cancer medicines, both biosimilars and generics, with a strategy that includes an attempt to reduce anticompetitive behavior, according to Scott Gottlieb, MD, commissioner of the FDA.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
Oncology Nurse Advisor
Neuroblastoma survivors are at elevated risk for psychological impairment, according to a study published online June 11 in Cancer.
Daniel J. Zheng, MD, from Yale University in New Haven, Conn., and colleagues evaluated the long-term psychological and educational outcomes of 859 survivors of neuroblastoma (≥5-year survivors of neuroblastoma younger than 18 years) and 872 siblings of childhood cancer survivors (younger than 18 years). Over a median follow-up of 13.3 years, the researchers found that neuroblastoma survivors had an increased prevalence of impairment in the domains of anxiety/depression, headstrong behavior, attention deficits, peer conflict/social withdrawal and antisocial behavior, compared to siblings.
READ MORE
Phys.Org
A new anticancer agent developed by the University of Warwick has been studied using microfocus synchrotron X-ray fluorescence (SXRF) at I18 at Diamond Light Source. As described in the Journal of Inorganic Biochemistry, researchers saw that the drug penetrated ovarian cancer cell spheroids and the distribution of zinc and calcium was perturbed. Platinum-based chemotherapy agents are used to treat many cancer patients, but some can develop resistance to them. To address this issue, scientists from the University of Warwick sought to employ alternative precious metals.
READ MORE
|
Promoted by
|
|
|
|
 |
Medical Xpress
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life enhanced. However, two or three years after the start of treatment, some patients develop an aggressive B-cell lymphoma. In a close collaboration between researchers from MedUni Vienna and Vetmeduni Vienna, it has now been shown for the first time that JAK2 inhibitors awaken "dormant" lymphomas in the bone marrow and hence cancer.
READ MORE
ScienceDaily
Researchers have developed a computer program, which has revealed a previously unknown combination of drugs that may be the answer to Triple Negative Breast Cancer (TNBC), using genetic and treatment data from TNBC cells grown in labs and from hundreds of patients world-wide. Importantly, researchers can tell by inputting patients' genomic and proteomic information into their computer model who may benefit from this drug combination or not — saving precious time.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
Medical News Today
A six-year research project identifies 63 gene changes that could help to indicate an increased risk of prostate cancer in certain men. The study was conducted at Case Western Reserve University School of Medicine in Cleveland, OH, and the results are now published Nature Genetics.
Cancer epidemiology researcher Frederick R. Schumacher, PhD, led an international team comprising over 100 researchers. These genetic markers might make it easier to determine the necessity, as well as the rate, of regular prostate cancer screenings.
READ MORE
Medical News Today
Scientists have found that blocking certain proteins that respond to the hormone progesterone may prevent breast cancer in those who carry high-risk genes. The proteins are called epigenetic proteins and they cause "mammary gland stem cell" numbers to expand when exposed to progesterone.
READ MORE
| ACS CANCER PROGRAMS UPDATES |
ACS
The American College of Surgeons (ACS) 2018 Cancer Programs Annual Conference: Learn. Interact. Transform provides cutting-edge solutions to help you deliver high-quality, patient-centered, multidisciplinary care to patients with cancer. Through a combination of plenaries, breakout sessions and networking opportunities you will leave this conference reinvigorated and ready to overcome the challenges facing you as a cancer care provider.
Conference Highlights:
- CoC Accreditation 101 and Pursing Excellence though NAPBC Accreditation Pre-Conference Workshops on Wednesday, Sept 5
- Value of Navigation and Survivorship
- Mock Tumor Boards
- Components of a Quality Study
- Poster Sessions (we are still accepting applications – submit poster submission today)
- Exhibits
Detailed information, as well as conference agenda, can be found on the Cancer Programs Annual Conference website.
Register Now to take advantage of the early bird registration fee and SAVE.
READ MORE
ACS
U.S. Rep. Mike Thompson (D-CA), a member of the House of Representatives Ways and Means Committee, sponsored a Stop the Bleed® training session for Congressional staff this morning. Surgeon members of the American College of Surgeons (ACS) instructed more than 75 people on how to stop potentially life-threatening bleeding in an injured person.
READ MORE
ACS
The 2018 Cancer Programs Annual Conference: Learn. Interact. Transform will be held in Chicago, Sept. 5-7. Be a part of this exciting conference that is targeted to health care providers committed to providing comprehensive, multidisciplinary, high-quality, patient-centered care. Share your knowledge and expertise with your peers and colleagues by responding to the call for posters. Complete submissions are due by Friday, July 6. For additional information, refer to the Poster/Resource Submission application.
READ MORE
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neo-plastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2, 2018
Special 25 percent discount expires Sept. 30!
Order your copy today.
The AJCC is considering making the AJCC Cancer Staging Manual, Eighth Edition available in electronic format. We would greatly appreciate your feedback to understand if an electronic version of the 8th Edition would meet an unfulfilled need for our readers and, if so, what would be the optimal platform for distribution.
Please take two minutes to complete the brief survey and let us know your thoughts. The survey will close at 12 p.m. CDT, Friday, June 22.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
| IMPORTANT DATES AND DEADLINES |
| Date |
Event |
Location |
| July 21-24 |
ACS Quality and Safety Conference
|
Orlando, FL
|
| Sept. 5-7 |
2018 Cancer Programs Conference
|
Chicago, IL
|
| Oct. 21-25 |
ACS Clinical Congress
|
Boston, MA
|
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
